Showing results (71-80 of 250) with videos related to

Sort By:
Pageof 25
The American Journal of Cardiology|January 4, 2016
Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney DiseaseNishank Jain, Xilong Li, Beverley Adams-Huet, et al.
Transfusion|July 3, 2015
Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversalMajed A Refaai, Joshua N Goldstein, Martin L Lee, et al.
Blood Reviews|March 23, 2015
Transfusions for anemia in adult and pediatric patients with malignanciesNeil Shah, Jennifer Andrews, Lawrence Tim Goodnough
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 11, 2005
Antigen-IgE desensitization in signal transducer and activator of transcription 6-deficient mast cells by suboptimal doses of antigenAlexander Rodriguez Morales, Neil Shah, Mariana Castells
Dental Update|January 14, 2012
Dislodged lower right third molar tooth into the parapharyngeal spaceRhiyoma Monique Ogadako, Martin Woods, Neil Shah
World Journal of Clinical Cases|July 18, 2014
Verrucous carcinoma of the esophagus: A case report and literature reviewChintan Ramani, Neil Shah, Ramasamy Swami Nathan
The British Journal of Oral & Maxillofacial Surgery|September 16, 2008
Synchronous unilateral pleomorphic adenomas in the parotid gland: report of a caseDarryl M Coombes, Reem Kaddour, Neil Shah
Circulation|August 13, 2013
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb studyRavi Sarode, Truman J Milling, Majed A Refaai, et al.
Blood Advances|August 12, 2020
Physical activity in children at risk of postthrombotic sequelae: a pilot randomized controlled trialRida Hasan, Maria Hanna, Song Zhang, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Tailoring caplacizumab administration using ADAMTS13 activity for immune-mediated thrombotic thrombocytopenic purpuraSean G Yates, Sandra L Hofmann, Ibrahim F Ibrahim, et al.
Pageof 25